Global Healthcare Artificial Intelligence Market – North America is expected to account for higher market share of more than 30% driven due to increased demand for big data analytics in the healthcare sector – Market Analysis and Forecast 2019 – 2026

Global Healthcare Artificial Intelligence Market – North America is expected to account for higher market share of more than 30% driven due to increased demand for big data analytics in the healthcare sector – Market Analysis and Forecast 2019 – 2026

Market Scenario

Global Healthcare Artificial Intelligence Market is likely to grow at CAGR of around 41% and will exceed over USD XX billion by 2026. Global Healthcare Artificial Intelligence Market Global Healthcare Artificial Intelligence Market growth is primarily driven by increasing demand precision medicines, rising clinical research, safeguarding the healthcare data. Other factors such as increasing adoption of disease detection technologies including CT scans, MRI scans, and PAC also drive the market for Healthcare Artificial Intelligence through the forecast period. Global Healthcare Artificial Intelligence Market Overview, By Region North America expected to have larger market share primarily due to increased demand for big data analytics in the healthcare sector. Other major factors which drive the Healthcare Artificial Intelligence market in this region is government initiatives for the adoption of artificial intelligence, encouragement for the big data analytics from the federal government also drive the market for AI in the healthcare sector. Global Healthcare Artificial Intelligence Market Overview, By Applications Drug discovery is expected to account for a higher market share in 2016. This market is driven due to increasing demand for research and development of drugs such as, designing the drug, identification molecules and screening the molecules. Global Healthcare Artificial Intelligence Market Overview, By Offering Software segment is expected to account for a higher market share in 2016. This market is driven due to increased demand big data analytic software in the medical field and increasing companies which provide the software services for the AI in the medical field. Continuous innovation in the AI software’s of the healthcare sector also drive the market through the forecast period. Global Healthcare Artificial Intelligence Market Overview, By Market Players Increasing healthcare expenditure by all the regions also drive the market for Healthcare Artificial Intelligence through the forecast period. Some of the companies operating in Healthcare Artificial Intelligence Market are Atomise, carbon, Circadian Health, IBM Watson Health, Pathway Genomics, Intel Corporation, Next IT Corp., Google, Inc., Microsoft Corporation, and General Electric Company. Global Healthcare Artificial Intelligence Market Background Developing countries such as China and India are increasing their investments in the healthcare sectors. Other private organizations in the developing countries also investing in the healthcare infrastructures. These factors drive the market for Healthcare Artificial Intelligence through the forecast period. The objective of the report is to present comprehensive analysis of Global Healthcare Artificial Intelligence market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Healthcare Artificial Intelligence market dynamics, structure by analyzing the market segments, and project the Global Healthcare Artificial Intelligence market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Healthcare Artificial Intelligence market make the report investor’s guide.

Global Healthcare Artificial Intelligence Market Segmentation

Global Healthcare Artificial Intelligence Market, By Applications

o Medical Imaging & Diagnosis o Drug Discovery o Therapy Planning o Hospital Workflow o Others

Global Healthcare Artificial Intelligence Market, By Offering

o Hardware o Software o Services The above data will be provided for following regions/countries (USD Million) • North America o U.S. o Canada • Europe o Germany o UK o France o Spain o Italy • Asia Pacific o China o India o Japan o Australia • Latin America o Argentina o Brazil o Mexico • Middle East and Africa o South Africa o Saudi Arabia

Table of Contents

Global Healthcare Artificial Intelligence Market

Chapter 1 Research Methodology .1.1. Research Methodology .1.2. Market definition .1.3. Assumptions and Acronyms Used .1.4. Data Sources .1.4.1. Secondary .1.4.1.1. Paid .1.4.1.2. Unpaid .1.4.2. Primary Chapter 2 Executive Summary .2.1. Global Healthcare Artificial Intelligence Market overview .2.1.1. By Applications Chapter 3 Global Healthcare Artificial Intelligence Market Industry Insights .3.1. Market segmentation and scope of study .3.2. Market Drivers and their impact analysis .3.2.1. Market Drivers .3.2.1.1. Innovation in clinical research and robotic personal assistants .3.2.2. Market Restraints .3.2.2.1. Apprehensions regarding adoption of artificial intelligence technology .3.3. Market share analysis .3.3.1. By Applications .3.4. Competitive analysis .3.4.1. Key strategic initiatives .3.4.2. Regional presence .3.4.3. Product overview .3.5. Porter’s analysis .3.6. PESTEL analysis Chapter 4 Healthcare Artificial Intelligence Market, By Applications .4.1. Key segment trends .4.2. Medical Imaging & Diagnosis .4.2.1. Market size, by region, 2019 - 2026 .4.3. Drug Discovery .4.3.1. Market size, by region, 2019 - 2026 .4.4. Therapy Planning .4.4.1. Market size, by region, 2019 - 2026 .4.5. Hospital Workflow .4.5.1. Market size, by region, 2019 - 2026 .4.6. Others .4.6.1. Market size, by region, 2019 - 2026 Chapter 5 Healthcare Artificial Intelligence Market, By Offering .5.1. Key segment trends .5.2. Hardware .5.2.1. Market size, by region, 2019 - 2026 .5.3. Software .5.3.1. Market size, by region, 2019 - 2026 .5.4. Therapy Planning .5.4.1. Market size, by region, 2019 - 2026 .5.5. Services .5.5.1. Market size, by region, 2019 - 2026 Chapter 6 Healthcare Artificial Intelligence Market, By Region .6.1. Key regional trends .6.2. North America .6.2.1. Market size, by country, 2019 - 2026 .6.2.2. Market size, by applications, 2019 - 2026 .6.3. U.S. .6.3.1. Market size, by applications, 2019 - 2026 .6.4. Canada .6.4.1. Market size, by applications, 2019 - 2026 .6.5. Europe .6.5.1. Market size, by country, 2019 - 2026 .6.5.2. Market size, by applications, 2019 - 2026 .6.6. Germany .6.6.1. Market size, by applications, 2019 - 2026 .6.7. UK .6.7.1. Market size, by applications, 2019 - 2026 .6.8. France .6.8.1. Market size, by applications, 2019 - 2026 .6.9. Spain .6.9.1. Market size, by applications, 2019 - 2026 .6.10. Italy .6.10.1. Market size, by applications, 2019 - 2026 .6.11. Sweden .6.11.1. Market size, by applications, 2019 - 2026 .6.12. Asia Pacific .6.12.1. Market size, by country, 2019 - 2026 .6.12.2. Market size, by applications, 2019 - 2026 .6.13. India .6.13.1. Market size, by applications, 2019 - 2026 .6.14. China .6.14.1. Market size, by applications, 2019 - 2026 .6.15. Japan .6.15.1. Market size, by applications, 2019 - 2026 .6.16. Australia .6.16.1. Market size, by applications, 2019 - 2026 .6.17. Latin America .6.17.1. Market size, by country, 2019 - 2026 .6.17.2. Market size, by applications, 2019 - 2026 .6.18. Argentina .6.18.1. Market size, by applications, 2019 - 2026 .6.19. Brazil .6.19.1. Market size, by applications, 2019 - 2026 .6.20. Mexico .6.20.1. Market size, by applications, 2019 - 2026 .6.21. Middle East and Africa .6.21.1. Market size, by country, 2019 - 2026 .6.21.2. Market size, by applications, 2019 - 2026 .6.22. South Africa .6.22.1. Market size, by applications, 2019 - 2026 .6.23. Saudi Arabia .6.23.1. Market size, by applications, 2019 - 2026 Chapter 7 Consolidations .7.1. Mergers and Acquisitions .7.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements .7.3. Patent Analysis Chapter 8 Key Players  .8.1. IBM Watson Health .8.1.1. Company overview .8.1.2. Key financials .8.1.3. Product landscape .8.1.4. Strategic initiatives .8.1.5. SWOT analysis .8.2. iCarbonX .8.2.1. Company overview .8.2.2. Key financials .8.2.3. Product landscape .8.2.4. Strategic initiatives .8.2.5. SWOT analysis .8.3. Pathway Genomics .8.3.1. Company overview .8.3.2. Key financials .8.3.3. Product landscape .8.3.4. Strategic initiatives .8.3.5. SWOT analysis .8.4. AiCure .8.4.1. Company overview .8.4.2. Key financials .8.4.3. Product landscape .8.4.4. Strategic initiatives .8.4.5. SWOT analysis .8.5. Atomwise .8.5.1. Company overview .8.5.2. Key financials .8.5.3. Product landscape .8.5.4. Strategic initiatives .8.5.5. SWOT analysis .8.6. Cyrcadia Health .8.6.1. Company overview .8.6.2. Key financials .8.6.3. Product landscape .8.6.4. Strategic initiatives .8.6.5. SWOT analysis .8.7. Intel Corporation .8.7.1. Company overview .8.7.2. Key financials .8.7.3. Product landscape .8.7.4. Strategic initiatives .8.7.5. SWOT analysis .8.8. Google, Inc. .8.8.1. Company overview .8.8.2. Key financials .8.8.3. Product landscape .8.8.4. Strategic initiatives .8.8.5. SWOT analysis .8.9. F. NVIDIA .8.9.1. Company overview .8.9.2. Key financials .8.9.3. Product landscape .8.9.4. Strategic initiatives .8.9.5. SWOT analysis .8.10. Microsoft Corporation .8.10.1. Company overview .8.10.2. Key financials .8.10.3. Product landscape .8.10.4. Strategic initiatives .8.10.5. SWOT analysis .8.11. iCarbonX .8.11.1. Company overview .8.11.2. Key financials .8.11.3. Product landscape .8.11.4. Strategic initiatives .8.11.5. SWOT analysis .8.12. Next IT Corp. .8.12.1. Company overview .8.12.2. Key financials .8.12.3. Product landscape .8.12.4. Strategic initiatives .8.12.5. SWOT analysis .8.13. Welltok, Inc. .8.13.1. Company overview .8.13.2. Key financials .8.13.3. Product landscape .8.13.4. Strategic initiatives .8.13.5. SWOT analysis .8.14. General Vision, Inc. .8.14.1. Company overview .8.14.2. Key financials .8.14.3. Product landscape .8.14.4. Strategic initiatives .8.14.5. SWOT analysis .8.15. Enlitic, Inc. .8.15.1. Company overview .8.15.2. Key financials .8.15.3. Product landscape .8.15.4. Strategic initiatives .8.15.5. SWOT analysis .8.16. Recursion Pharmaceuticals .8.16.1. Company overview .8.16.2. Key financials .8.16.3. Product landscape .8.16.4. Strategic initiatives .8.16.5. SWOT analysis .8.17. General Electric Company .8.17.1. Company overview .8.17.2. Key financials .8.17.3. Product landscape .8.17.4. Strategic initiatives .8.17.5. SWOT analysis

About This Report

Report ID9847
Category Healthcare
Published Date
No of Pages195
Contact Us